Bill bans corporate ownership of medical practices, restricts MSO control of physician decisions

What it does

This bill prohibits non-physician-owned corporations from owning medical practices or employing physicians, and bans non-compete agreements for physicians except when they own at least 25% of the practice. It also restricts management services organizations (MSOs) from controlling clinical decisions, hiring, compensation, or operational details of medical practices. Physicians and advanced practice providers benefit by gaining autonomy and ownership protection; patients may benefit from reduced corporate cost-cutting pressure on clinical care.

Why we flagged it

The bill's core mechanism is a prohibition on non-physician-owned entities controlling medical practices, paired with restrictions on MSO operational control and non-compete clauses. This is fundamentally a regulatory restriction on corporate consolidation in healthcare, framed as physician protection.

What the text implies

• The 1-year effective date creates a transition period during which existing corporate-owned practices must divest or restructure, potentially triggering rapid consolidation among physician-owned entities and disrupting care continuity.
• The definition of 'practice of medicine' in subsection (d)(4)(B) is broad enough to capture administrative decisions (e.g., EHR configuration, coding standards) as clinical control, which may expose MSOs to liability for routine business functions.
• The bill exempts hospitals and hospital-affiliated clinics, creating a two-tier system where hospital-employed physicians remain subject to corporate control while independent practices do not—potentially accelerating physician employment by hospitals as a workaround.
• The treble damages and private right of action provisions may generate significant litigation risk for MSOs and healthcare companies, potentially chilling legitimate service contracts and increasing legal costs.
• State preemption language allows states to impose stricter requirements, creating a patchwork of rules that may fragment national healthcare service providers and increase compliance complexity.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill protects physician autonomy and clinical independence from corporate cost-cutting and operational control, which directly affects patient care quality and physician ability to make medically sound decisions. It also restricts non-compete clauses that limit physician mobility and patient access to preferred providers. However, the bill may increase administrative costs for smaller practices and could reduce access in underserved areas if corporate consolidation was previously subsidizing

Who stands to gain

• Physician-owned medical practices
• Advanced practice providers (PAs, NPs) in independent practices
• Healthcare litigation firms (treble damages + private right of action)
• Physician recruitment and staffing firms (reduced non-compete restrictions)

Named in the bill

Federal Trade Commission (FTC), Management Services Organizations (MSOs), Physicians, Advanced Practice Providers (PAs, NPs), Hospitals, Critical Access Hospitals, Rural Emergency Hospitals, State Attorneys General, Department of Health and Human Services

Where it stands

2 cosponsors: 2 Democrats.

• Sep 16, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Sep 16, 2026 — Referred to Senate Committee on Commerce, Science, and Transportation · Congress.gov: “Read twice and referred to the Committee on Commerce, Science, and Transportation”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.